Fluxome Sciences Expands Capital by DKK 100 mio /EUR 13 mio.COPENHAGEN, Denmark -- In a European biotech investment environment under pressure, fast-growing Danish biotech company Fluxome Sciences A/S announces a capital increase of DKK DKK In currencies, this is the abbreviation for the Danish Krone. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 100 mio/EUR 13 mio. The DKK 100 mio/EUR 13 mio capital increase has been secured through a continued strong commitment from current investors SEVENTURE Partners (France), INCUBA Venture (Denmark), VECATA A/S (Denmark) and the addition of one of Europe's leading cleantech funds, Capricorn Cleantech Fund, managed by CAPRICORN Venture Partners (Belgium), to the group of share holders. "I am very satisfied with the strengthening of our capital foundation and panel of investors", Chairman of the Board of Fluxome Sciences, Erik Hojsholt says. "The capital increase of DKK 100 mio will provide the capital needed to continue the execution of Fluxome's ambitious growth strategy." The capital increase confirms the significant interest venture capital market has shown Fluxome as a result of the company's very positive development. Three weeks ago, Fluxome announced entering into a strategic partnership agreement with CP Kelco U.S. Inc., a unit of J.M. Huber Corporation, to jointly develop and commercialize fermentation derived resveratrol res·ver·a·trol n. A natural compound found in grapes, mulberries, peanuts, and other plants or food products, especially red wine, that may protect against cancer and cardiovascular disease by acting as an antioxidant, antimutagen, and . The agreement will support accelerating the planned market introduction - expected as early as autumn 2008. Fluxome's vision is to become one of the global leading companies in the development, production and marketing of nutraceutical ingredients - a group of compounds with documented health benefits. Nutraceutical ingredients are used in dietary supplements and foods and represent a fast growing market; in 2007 worth a value of USD USD In currencies, this is the abbreviation for the U.S. Dollar. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 8 billion on ingredients alone. This market is expected to double before 2015. Besides resveratrol, Fluxome's pipeline offers a range of other nutraceutical ingredients, amongst others several unsaturated fatty acids unsaturated fatty acids, n.pl the double- or triple-bonded fatty acids contained primarily in vegetable oils and fish, which remain liquid at room temperature; linked to a reduction in the risk of developing heart disease. (PUFA PUFA polyunsaturated fatty acid. PUFA abbr. polyunsaturated fatty acid PUFA polyunsaturated fatty acids. ) of which the first will see market introduction during 2010. "Our capital increase enables us to continue the company's successful growth", says Fluxome's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Steen Andersen. "We will be developing our technology platform even further and focus on realization of our business strategy objectives. The transaction is an important step in the transformation from a technology platform structure to a product based company. I am extremely pleased with the large interest we have experienced from the global venture environment. This is a clear token of recognition towards our business and long-term strategy documented by the very promising results we have achieved so far through the efforts of our highly motivated team of employees." About Fluxome Sciences A/S Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology The references in this article would be clearer with a different and/or consistent style of citation, footnoting or external linking. Industrial biotechnology (known mainly in Europe as white biotechnology . Fluxome uses its proprietary, cutting-edge microbial microbial pertaining to or emanating from a microbe. microbial digestion the breakdown of organic material, especially feedstuffs, by microbial organisms. metabolic engineering Metabolic engineering is the practice of optimizing genetic and regulatory processes within cells to increase the cells' production of a certain substance. Metabolic engineers commonly work to reduce cellular energy use (ie, the energetic cost of cell reproduction or technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. More information can be found at our website: www.fluxome.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion